炎症复合评分可预测晚期HIV患者分枝杆菌免疫重建炎症综合征
这项前瞻性国际队列研究在未接受抗逆转录病毒治疗且CD4+计数<100个/mm3的HIV感染者中,于治疗前检测血浆生物标志物,开发了包含IL-6、IL-10、IL-27、sCD14、IFN-γ、TNF-α、透明质酸、D-二聚体、BMI和血红蛋白的复合评分,该评分能准确预测分枝杆菌IRIS和死亡。
要点
- 基线炎症标志物谱可预测严重免疫抑制HIV感染者的IRIS。
- 复合评分整合10项生物标志物和临床指标预测分枝杆菌IRIS和死亡。
- 该评分有助于启动ART的淋巴细胞减少HIV感染者的风险分层。
核心结论
- 严重免疫抑制HIV感染者的系统性炎症谱可预测IRIS。
- 预测分枝杆菌IRIS和死亡的复合评分可用于启动ART前的风险分层。
研究设计与样本
- 前瞻性国际队列研究,纳入美国、肯尼亚和泰国未接受ART且CD4+计数<100个/mm3的HIV感染者。
- 在ART启动前检测血浆生物标志物,进行多参数分析并开发复合评分预测模型。
主要发现
- 后续发生分枝杆菌或病毒性IRIS的参与者具有独特的基线炎症谱和炎症网络变化。
- 包含IL-6、IL-10、IL-27、sCD14、IFN-γ、TNF-α、透明质酸、D-二聚体、BMI和血红蛋白的复合评分能准确预测分枝杆菌IRIS和死亡。
关键数值与推荐
- 复合评分纳入的10项指标:IL-6、IL-10、IL-27、sCD14、IFN-γ、TNF-α、透明质酸、D-二聚体、BMI和血红蛋白。
- 研究人群为CD4+计数<100个/mm3的未接受ART的HIV感染者。
临床怎么用
- 对于CD4+计数<100个/mm3且即将启动ART的HIV感染者,可考虑使用该复合评分进行分枝杆菌IRIS和死亡的风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immune reconstitution inflammatory syndrome (IRIS) is a common cause of morbidity among people with human immunodeficiency virus (PWH) who initiate antiretroviral therapy (ART) with severe lymphopenia. Easily accessible tools that reliably predict emergence and elucidate pathogenesis of IRIS are needed to facilitate improved clinical management. METHODS: Plasma levels of biomarkers were measured before ART initiation in a large multinational cohort of ART-naive PWH with severe immunosuppression (CD4+ count <100 cells/mm3) in United States, Kenya, and Thailand. We performed a series of multiparametric analyses of inflammatory and clinical biomarkers and developed a composite score merging relevant biomarkers for use in a prediction model. RESULTS: We identified a distinct baseline inflammatory profile and changes in inflammatory networks among biomarkers in participants who subsequently developed mycobacterial or viral IRIS. We also developed a composite score incorporating biomarkers associated with IRIS (interleukin-6 [IL-6], IL-10, IL-27, sCD14, interferon-γ, tumor necrosis factor-α, hyaluronic acid, D-dimer, body mass index, and hemoglobin) that accurately predicted mycobacterial IRIS and death in this cohort. CONCLUSIONS: Systemic inflammatory profiles in PWH with severe immunosuppression are predictive of IRIS. Composite scores for the prediction of mycobacterial IRIS and death could be useful for risk stratification in PWH and lymphopenia initiating ART. CLINICAL TRIALS REGISTRATION: NCT00286767.
引用
- Vinhaes CL, Sheikh V, Oliveira-de-Souza D, et al. An Inflammatory Composite Score Predicts Mycobacterial Immune Reconstitution Inflammatory Syndrome in People with Advanced HIV: A Prospective International Cohort Study. J Infect Dis. 2021. PMID: 32761193. doi:10.1093/infdis/jiaa484
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。